Pfizer's Options Market See Big Money Take Bullish Stance, Benzinga Reports

Deep-pocketed investors have adopted a bullish approach towards $Pfizer (PFE.US)$, Benzinga reported, citing nine extraordinary options activities for the stock. The report showed about 44% of the trades were leaning bullish and 44% bearish.

Of the notable options cited by Benzinga, five were puts, totaling $273,893, and four were calls, amounting to $302,325. The volume and open interest on these contracts signal the whales behind them may have been targeting a price range of $17.5 to $35.0 for Pfizer over the last 3 months, according to the report. While the shares were up 0.3% to $25.34 at 10:26 a.m. in New York, they're still near the lowest since 2020. Read the full report here: Options Corner: Pfizer's Options Market Sees Big Money Take Bullish Stance